Jonsson Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.ucla.edu

Clinical Trials

Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-05-15

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00005079

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸
Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States

Biological Therapy in Treating Patients With Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-04-04

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00039299

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma

Phase 2

Conditions: Lymphoma

First Posted Date: 2003-01-27

Last Posted Date: 2013-12-19

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00042913

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer

Phase 2

Withdrawn

Conditions: Stage IV Renal Cell Cancer
Recurrent Renal Cell Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-07-10

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00040989

Locations: 🇺🇸
Emory University Hospital - Atlanta, Atlanta, Georgia, United States
🇺🇸
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States
🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States

and more 23 locations

Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2003-01-27

Last Posted Date: 2013-07-10

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00045318

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸
Cancer Therapy and Research Center, San Antonio, Texas, United States
🇺🇸
Veterans Affairs Medical Center - San Antonio (Murphy), San Antonio, Texas, United States

and more 2 locations

STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia

Phase 1

Completed

Conditions: Leukemia

First Posted Date: 2003-01-27

Last Posted Date: 2013-06-24

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00015860

Locations: 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

and more 2 locations

Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia

Phase 2

Completed

Conditions: Lymphoma

First Posted Date: 2003-01-27

Last Posted Date: 2013-01-08

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 7

Registration Number: NCT00020800

Locations: 🇸🇪
Huddinge University Hospital, Stockholm, Sweden
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Barrett Cancer Center, Cincinnati, Ohio, United States

and more 15 locations

Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer

Not Applicable

Completed

Conditions: Brain and Central Nervous System Tumors
Cognitive/Functional Effects
Fatigue

Interventions: Drug: modafinil

First Posted Date: 2003-01-27

Last Posted Date: 2020-08-03

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 29

Registration Number: NCT00052286

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States

Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-09-20

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00020995

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy

Phase 3

Conditions: Ovarian Cancer
Primary Peritoneal Cavity Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-09-17

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00004115

Locations: 🇬🇧
Antisoma, London, England, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy